SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001640334-24-000388
Filing Date
2024-03-12
Accepted
2024-03-12 17:09:55
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-1 lxrp_s1.htm S-1 245032
2 LEGAL OPINION lxrp_ex51.htm EX-5.1 6258
3 CONSENT lxrp_ex231.htm EX-23.1 1454
4 CONSENT lxrp_ex232.htm EX-23.2 3736
5 FILLING FEE lxrp_ex107.htm EX-FILING FEES 23523
6 lxrp_s1img3.jpg GRAPHIC 14676
7 lxrp_s1img4.jpg GRAPHIC 14676
8 lxrp_ex233img2.jpg GRAPHIC 4674
9 lxrp_ex233img3.jpg GRAPHIC 7049
  Complete submission text file 0001640334-24-000388.txt   338242
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-1 | Act: 33 | File No.: 333-277863 | Film No.: 24743263
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)